Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
3.440
+0.080 (2.38%)
At close: Aug 28, 2025, 4:00 PM
3.460
+0.020 (0.58%)
After-hours: Aug 28, 2025, 7:56 PM EDT
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $227.47 million as of August 28, 2025. Its market cap has increased by 907.83% in one year.
Market Cap
227.47M
Enterprise Value
297.16M
1-Year Change
907.83%
Ranking
Category
Stock Price
$3.44
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $227.47M, a decrease of -51.06%. That is a compound annual growth rate of -9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 222.18M | 147.97% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |